✦ LIBER ✦
Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy
✍ Scribed by E. Cock; J. Hutton; P. Canney; J. J. Body; P. Barrett-Lee; M. P. Neary; G. Lewis
- Publisher
- Springer-Verlag
- Year
- 2005
- Tongue
- English
- Weight
- 200 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.